• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 06 Oct 2021

    Jul-Sep'21 Earnings Preview - IPM to drive growth, US on slow progression

    buy
    Pharmaceuticals & Biotech.
    by Prabhudas Lilladhar
    Prabhudas Lilladhar
    believe that ease in RT/PCR tests will remain intact, while demand for core Acc=Accumulate / UR=Under Review tests may increase with digitalization in diagnostic segment. Similarly, as vaccination ratio improves, less impact is expected from newer COVID wave....
    Copy Link Share on Share on Share on Share on
    Alert  
    Axis Direct released a Sector Update report for Pharmaceuticals & Biotech. on 09 Jul, 2025.
    More from Pharmaceuticals & Biotech.
    Recommended
    Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
    Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
    Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
    The Baseline | 10 Jul 2025, 12:14PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd